Assessing patients' perceived bother from the gastrointestinal side effects of radiotherapy for localized prostate cancer: Initial questionnaire development and validation

Acta Oncologica

Volumn 53, Issue 3, 2014, Pages 368-377

  Pettersson, Anna ^a   Turesson, Ingela ^a   Persson, Christina ^a   Johansson, Birgitta ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL CRAMP; ABDOMINAL PAIN; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CONCURRENT VALIDITY; CONSTIPATION; CONTENT VALIDITY; CONTROLLED STUDY; DIARRHEA; FLATULENCE; GASTROINTESTINAL SYMPTOM; HUMAN; INTERNAL CONSISTENCY; INTESTINE GAS; MAJOR CLINICAL STUDY; MUCUS DISCHARGE; OPEN ENDED QUESTIONNAIRE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOMETRY; RECTAL IRRITATION; RECTAL PAIN; RECTUM DISEASE; RECTUM HEMORRHAGE; SENSITIVITY AND SPECIFICITY; ASSESSMENT OF HUMANS; COMPARATIVE STUDY; CORRELATION ANALYSIS; CRONBACH ALPHA COEFFICIENT; DEFECATION URGENCY; FACE VALIDITY; FEASIBILITY STUDY; GASTROINTESTINAL SIDE EFFECTS QUESTIONNAIRE; MALE; PATIENT ATTITUDE; PATIENT REFERRAL; PREDICTIVE VALUE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM IRRITATION; RECTUM PAIN; RELIABILITY;

GASTROINTESTINAL DISEASES; HUMANS; MALE; PERCEPTION; PROSTATIC NEOPLASMS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY; REPRODUCIBILITY OF RESULTS; SOCIAL VALIDITY, RESEARCH;

EID: 84894222364     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.819994     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Wahlgren T, Nilsson S, Ryberg M, Lennernas B, Brandberg Y. Combined curative radiotherapy including HDR brachytherapy and androgen deprivation in localized prostate cancer: A prospective assessment of acute and late treatment toxicity Acta Oncol 2005;44:633-43.
3. Heemsbergen WD, Peeters ST, Koper PC, Hoogeman MS, Lebesque JV. Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: Consequential late damage. Int J Radiat Oncol Biol Phys 2006;66:3-10.
4. Lesperance RN, Kjorstadt RJ, Halligan JB, Steele SR. Colorectal complications of external beam radiation versus brachytherapy for prostate cancer. Am J Surg 2008;195: 616-20; discussion 20.
5. Yeoh EK, Holloway RH, Fraser RJ, Botten RJ, Di Matteo AC, Butters J. Pathophysiology and natural history of anorectal sequelae following radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2012;84: e593-9.
6. Tagkalidis PP, Tjandra JJ. Chronic radiation proctitis. ANZ J Surg 2001;71:230-7.
7. Phan J, Swanson DA, Levy LB, Kudchadker RJ, Bruno TL, Frank SJ. Late rectal complications after prostate brachy-therapy for localized prostate cancer: Incidence and management. Cancer 2009;115:1827-39.
8. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient? Br J Cancer 1988;57:109-12.
9. Spry N, Halkett G, Aoun S, Spry J, Yeoh E. Development of a European organization for research and treatment of cancer module to assess the quality of life of patients with proctitis after pelvic radiotherapy for malignancy. Int J Radiat Oncol Biol Phys 2008;72:522-8.
10. Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B. Patient-reported outcomes: Conceptual issues. Value Health 2007;10(Suppl 2):S66-75.
11. Reidunsdatter RJ, Lund JA, Fransson P, Widmark A, Fossa SD, Kaasa S. Validation of the intestinal part of the prostate cancer questionnaire QUFW94: Psychometric properties, responsiveness, and content validity. Int J Radiat Oncol Biol Phys 2010;77:793-804.
12. van Andel G, Bottomley A, Fossa SD, Efficace F, Coens C, Guerif S, et al. An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer 2008;44:2418-24.
13. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med Care 1998;36:1002-12.
14. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899-905.
15. Widmark A, Fransson P, Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 1994;74:2520-32.
16. Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: A theoretical model. Soc Sci Med 1999;48:1507-15.
17. McPhail S, Comans T, Haines T. Evidence of disagreement between patient-perceived change and conventional longitudinal evaluation of change in health-related quality of life among older adults Clin Rehabil 2010;24:1036-44.
18. Donohoe JE. To what extent can response shift theory explain the variation in prostate cancer patients reactions to treatment side-effects? A review. Qual Life Res 2011;20: 161-7.
19. Johansson S, Astrom L, Sandin F, Isacsson U, Montelius A, Turesson I. Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer. Prostate Cancer 2012;2012:654861.
20. Budaus L, Bolla M, Bossi A, Cozzarini C, Crook J, Widmark A, et al. Functional outcomes and complications following radiation therapy for prostate cancer: A critical analysis of the literature j Eur Urol 2012;61:112-27.
21. McPhail S, Haines T. Response shift, recall bias and their effect on measuring change in health-related quality of life amongst older hospital patients. Health Qual Life Outcomes 2010;8:65.
22. Pettersson A, Johansson B, Persson C, Berglund A, Turesson I. Effects of a dietary intervention on acute gastrointestinal side effects and other aspects of health-related quality of life: A randomized controlled trial in prostate cancer patients undergoing radiotherapy. Radiother Oncol 2012;103:333-40.
23. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
24. Streiner DL, Norman GR. Health Measurement Scales - a practical guide to their development and use, 4th ed. Oxford: Oxford University Press; 2008.
25. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34-42.
26. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
27. Morton GC, Loblaw DA, Chung H, Tsang G, Sankreacha R, Deabreu A, et al. Health-related quality of life after singlefraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2011;80:1299-305.
28. Mohammed N, Kestin L, Ghilezan M, Krauss D, Vicini F, Brabbins D, et al. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Int J Radiat Oncol Biol Phys 2012;82:204-12.
29. Sprangers MA, Van Dam FS, Broersen J, Lodder L, Wever L, Visser MR, et al. Revealing response shift in longitudinal research on fatigue - the use of the thentest approach. Acta Oncol 1999;38:709-18.
30. Fransson P. Recall of pretreatment symptoms among men treated with radiotherapy for prostate cancer. Acta Oncol 2005;44:355-61.
31. Magasi S, Ryan G, Revicki D, Lenderking W, Hays RD, Brod M, et al. Content validity of patient-reported outcome measures: Perspectives from a PROMIS meeting. Qual Life Res 2012;21:739-46.